Forecast
The analysts' average price target is €2.73 (+1,200.00%). The median is €2.73 (+1,200.00%).
| Buy |
4 |
| Hold |
2 |
| Sell |
0 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
Nanox closes distribution agreement for Nanox.ARC in Costa Rica
Nanox has signed a distribution agreement with SOLME RC, S.A. for the Nanox.ARC imaging system in Costa Rica. SOLME will handle marketing, sales, installation, training and technical support and is a registered supplier of the Caja Costarricense de Seguro Social. The market rollout follows a regulatory approval process with an initial six-month proof-of-concept phase for device registration; Costa Rica is Nanox’s third Latin American market this year after Argentina and Peru. » More on de.investing.com
Nano-X Imaging misses Q2 2026 revenue forecast — shares plunge sharply premarket
Nano-X Imaging reported Q2 2026 revenue of $4.2 million, well below the consensus forecast of $5.54 million. GAAP net loss widened to $55.5 million, mainly due to a $40.7 million impairment. The stock fell about 19% in premarket trading and was trading near its 52-week low; cash on hand at quarter-end stood at $31.4 million. Management points to advancing system installations, initial reimbursable claims in the Nanox Imaging Network and CMS code G0680 as potential revenue support, but plans further capital raises and cost cuts. » More on de.investing.com
Nanox closes distribution agreement with Associated X‑Ray for New England
Nanox announced that its US subsidiary Nanox Impact has signed a distribution agreement with Associated X‑Ray Imaging for the New England region. Associated X‑Ray will market, distribute and provide support for the FDA-cleared Nanox.ARC system, using its regional presence and service infrastructure. The cooperation is part of Nanox’s strategy to expand the Nanox.ARC sales network in selected US regions. » More on de.investing.com
Nano-X Imaging places registered direct placement of about $8 million
Nano-X Imaging has agreed to sell 8,000,000 common shares plus warrants for up to 8,000,000 additional shares at a combined price of $1.00 per share with accompanying warrant. The warrants have an exercise price of $1.15, become exercisable after six months and expire after five years. Expected gross proceeds are about $8 million before fees; the proceeds are intended for working capital and general corporate purposes. A.G.P./Alliance Global Partners is acting as sole placement agent and the issuance will be made by prospectus supplement under the shelf registration (Form F-3). » More on de.investing.com
Nano‑X Imaging announces quarterly results for 31 December 2025, analysts expect revenue growth
Nano‑X Imaging will release results for the quarter ended 31 December 2025 on 20 April 2026. Four analysts on average expect EPS of -0.223 USD (prior year -0.230 USD) and revenue to increase 33% to 4.0 Mio. USD (prior year 3.0 Mio. USD). For the completed fiscal year analysts forecast on average EPS of -0.873 USD and revenues of 13.3 Mio. USD (previously 11.3 Mio. USD). » More on finanzen.net
Financials
In the last quarter, Nano-X Imaging had revenue of €3.64m and net profit of -€48.62m
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 3.64m | 41.19% |
| Gross profit | -38.27m | 1,292.11% |
| Net profit | -48.62m | 289.24% |
| EBITDA | -46.14m | 371.18% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €18.93m |
Number of shares | 78.75m |
52-week high/low | €4.29 - €0.19 |
| Dividends | No |
Beta | 1.36 |
P/E ratio | -0.16 |
PEG ratio | 0.00 |
P/B ratio | 0.25 |
P/S ratio | 1.33 |
Company profile
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
| Name | Nano-X Imaging |
| CEO | Erez I. Meltzer |
| Headquarters | Petah Tikva,
Israel |
| Website | |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| IPO | 21/08/2020 |
| Employees | 197 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | NNOX |